Y S Ahn

No ORCID on file · 9 papers in corpus
review 2009
Acta haematologica ·doi:10.1159/000205048

Danazol, an attenuated androgen developed for the treatment of endometriosis, has recently been found useful in the treatment of several hematologic disorders, including idiopathic thrombocytopenic purpura (ITP), autoimmune hemolytic anemia…

review 1997
American journal of hematology ·doi:10.1002/(sici)1096-8652(199702)54:2<149::aid-ajh9>3.0.co;2-x

Paroxysmal nocturnal hemoglobinuria (PNH) is a rare clonal stem-cell disorder in which blood cells lack complement inhibiting membrane proteins, and become susceptible to complement-mediated injury, leading to chronic intravascular hemolysi…

nonrandomized-trial 1996
American journal of hematology ·doi:10.1002/(sici)1096-8652(199602)51:2<112::aid-ajh3>3.0.co;2-0

Severe pruritus is frequently associated with myeloproliferative and other systemic illnesses, and often fails to respond to conventional measures. We used danazol (Danocrine), a synthetic attenuated androgen, in the treatment of severe pru…

case-report 1993
Annals of internal medicine ·doi:10.7326/0003-4819-118-10-199305150-00021

Letters15 May 1993Danazol for Henoch-Schonlein PurpuraYoung J. Lee, MD, Lawrence L. Horstman, MD, and Yeon S. Ahn, MDYoung J. Lee, MDSearch for more papers by this author, Lawrence L. Horstman, MDSearch for more papers by this author, and Y…

other 1989
FASEB journal : official publication of the Federation of American Societies for Experimental Biology ·doi:10.1096/fasebj.3.2.2914627

Danazol, an attenuated androgen, is useful in endometriosis, idiopathic thrombocytopenic purpura (ITP), and autoimmune hemolytic anemia (AIHA). However, its mechanism of action is unknown. We investigated the possibility that danazol affect…

nonrandomized-trial 1989
Annals of internal medicine ·doi:10.7326/0003-4819-111-9-723

STUDY OBJECTIVE: To assess the long-term benefit and side effects of danazol therapy, and to delineate factors influencing the responses in patients with autoimmune thrombocytopenia. DESIGN: Before and after trial. SETTING: Referral-based…

nonrandomized-trial 1989
The American journal of the medical sciences ·doi:10.1097/00000441-198910000-00002

Danazol, an attenuated androgen, has been used successfully at its conventional dose (400-800 mg/day) in the treatment of idiopathic thrombocytopenic purpura (ITP). To minimize side effects, the authors tried a very low dose (50 mg/day) reg…

other 1986
The Journal of the Florida Medical Association
case-report 1985
Annals of internal medicine ·doi:10.7326/0003-4819-102-3-298

We evaluated the use of danazol in 15 patients with autoimmune hemolytic anemia of the warm antibody type. Danazol, 600 to 800 mg/d, was added to previous regimens or given initially in conjunction with high-dose prednisone treatment. Twelv…